Trial intelligence / Profile preview

RESULT-NOF: Transfusion Strategy in Hip Fracture

NCT03407573Completed

Sponsor
NHS Lothian
Start
Oct 2017
Primary completion
Mar 2019
Modality
Recombinant Proteins and Enzymes, Cell Therapies
Countries
1
01

Overview

Randomised, open-label trial of red blood cells in anemia (2 arms), sponsored by NHS Lothian. Primary endpoint: Myocardial Injury at 60 days. Started Oct 2017; status: completed.

02

Drugs

red blood cells
03

Conditions

anemia

Beyond the preview

Go deeper on NCT03407573.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03407573.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call